Octreotide in the Management of Chemoradiotherapy-Induced Diarrhea Refractory to Loperamide in Patients with Rectal Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|71|5-6|354-360

ISSN： 0030-2414

Source： Oncology, Vol.71, Iss.5-6, 2007-09, pp. : 354-360

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of Chemoradiotherapy-Induced Anemia on Survival in Uniformly Staged Patients with Locally Advanced Squamous Cell Carcinoma of the Esophagus

By  

Oncology Research and Treatment, Vol. 27, Iss. 5, 2004-10 ,pp. : 462-466

Karger

Access to resources Recommend Favorite

Effect of low‐level laser therapy on chemoradiotherapy‐induced oral mucositis and salivary inflammatory mediators in head and neck cancer patients

By  

LASERS IN SURGERY AND MEDICINE, Vol. 47, Iss. 4, 2015-04 ,pp. : 296-305

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapy for Patients with Rectal Carcinoma

By  

Oncology Research and Treatment, Vol. 22, Iss. 5, 1999-11 ,pp. : 436-441

Karger

Access to resources Recommend Favorite

Chemoradiotherapy for Locally Advanced Pancreatic Carcinoma in Elderly Patients

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 432-437

Karger

Access to resources Recommend Favorite

Which Patients Benefit from Preoperative Chemoradiotherapy for Intermediate Staged Rectal Cancer?

By  

Oncology Research and Treatment, Vol. 34, Iss. 1-2, 2011-01 ,pp. : 36-41

Karger

Access to resources Recommend Favorite